May 2, 2020Open Access

Oxidative Stress, GTPCH1, and Endothelial Nitric Oxide Synthase Uncoupling in Hypertension

YWYin WuHartford Hospital YDYe DingZhejiang Chinese Medical University TRTharmarajan RamprasathGeorgia State University

Structured PICO

Do eNOS activators improve efficacy for treating hypertension in preclinical models and humans?

Population

Preclinical models and humans with hypertension

Intervention

eNOS activators

Outcome

Efficacy for treating hypertension

This review examines the potential of eNOS activators as a therapeutic strategy for treating hypertension.

Abstract

to increase the efficacy for treating hypertension. Thus, this review also examines the current state of knowledge on the effects of eNOS activators on preclinical models and humans to utilize this information for potential therapy.

Demander à l'IA

Bookmark

View Full Paper

Cite This Study

Wu et al. (Sat,) studied this question.

synapsesocial.com/papers/6a005087b124fe581985d4cd https://doi.org/https://doi.org/10.1089/ars.2020.8112

Demander à l'IA

Bookmark

View Full Paper